![N-[2-[2-hydroxy-4-(methanesulfonamido)-5-phenoxyphenyl]-2-oxoethyl]formamide CAS 149457-03-4](/images/load_icon.gif){kind=icon}
![N-[2-[2-hydroxy-4-(methanesulfonamido)-5-phenoxyphenyl]-2-oxoethyl]formamide CAS 149457-03-4](/photo/pl169606810-n_2_2_hydroxy_4_methanesulfonamido_5_phenoxyphenyl_2_oxoethyl_formamide_cas_149457_03_4.jpg)
Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 149457-03-4
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
CAS NO:: |
149457-03-4 |
Appearance:: |
White To Off-White Powder |
Molecular Formula:: |
C16H16N2O6S |
Molecular Weight:: |
364.373 |
EINECS NO:: |
N/A |
MDL NO:: |
N/A |
CAS NO:: |
149457-03-4 |
Appearance:: |
White To Off-White Powder |
Molecular Formula:: |
C16H16N2O6S |
Molecular Weight:: |
364.373 |
EINECS NO:: |
N/A |
MDL NO:: |
N/A |
Product Description:
Product Name: N-[2-[2-hydroxy-4-(methanesulfonamido)-5-phenoxyphenyl]-2-oxoethyl]formamide CAS NO:149457-03-4
Synonyms:
Methanesulfonamide, N-[4-[2-(formylamino)acetyl]-5-hydroxy-2-phenoxyphenyl]-;
Chemical & Physical Properties:
Appearance: White to off-White Powder
Assay :≥99.0%
Density:1.4g/cm3
Boiling point:622.4℃ at 760 mmHg
Flash Point:330.2℃
Index of Refraction:1.628
Water Solubility: Very slightly soluble (0.11 g/L) (25 ºC)
Iguratimod intermediates.
Iguratimod is a new type of drug for the treatment of rheumatoid arthritis (RA) and osteoarthritis (OA) developed by Japan's Toyama company. Japan applied for marketing in 2003.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
